XIANGTAN ELECTROCHEMICAL SCIENTIFIC CO.,LTD Financials Xiangtan Electrochemical Scientific Co.,Ltd
Equities
002125
CNE100000064
Commodity Chemicals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.32 CNY | -3.75% |
|
-15.79% | +15.25% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,305 | 2,837 | 5,004 | 7,176 | 8,485 | 6,729 |
| Enterprise Value (EV) 1 | 3,312 | 3,974 | 6,184 | 8,561 | 9,891 | 7,763 |
| P/E ratio | 33.4 x | 42.8 x | 199 x | 30 x | 21.4 x | 19.1 x |
| Yield | 0.9% | - | 0.25% | 0.44% | 0.93% | 1.57% |
| Capitalization / Revenue | 2.14 x | 2.34 x | 4.05 x | 3.83 x | 4.04 x | 3.11 x |
| EV / Revenue | 3.07 x | 3.28 x | 5.01 x | 4.57 x | 4.71 x | 3.59 x |
| EV / EBITDA | 12.7 x | 14 x | 24.9 x | 25.3 x | 25.3 x | 15.5 x |
| EV / FCF | -32.5 x | -54.5 x | -13.6 x | -64.4 x | -550 x | 27.2 x |
| FCF Yield | -3.07% | -1.83% | -7.38% | -1.55% | -0.18% | 3.68% |
| Price to Book | 2 x | 2.37 x | 2.83 x | 3.6 x | 3.59 x | 2.42 x |
| Nbr of stocks (in thousands) | 5,52,960 | 5,52,960 | 6,29,482 | 6,29,482 | 6,29,482 | 6,29,482 |
| Reference price 2 | 4.169 | 5.130 | 7.950 | 11.40 | 13.48 | 10.69 |
| Announcement Date | 05/03/19 | 22/04/20 | 26/02/21 | 19/04/22 | 24/04/23 | 25/04/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1,079 | 1,210 | 1,234 | 1,872 | 2,100 | 2,163 |
| EBITDA 1 | 261.4 | 283.5 | 248.2 | 338.9 | 390.5 | 499.3 |
| EBIT 1 | 148.6 | 143.4 | 96.56 | 184.4 | 219.9 | 303.8 |
| Operating Margin | 13.78% | 11.85% | 7.82% | 9.85% | 10.47% | 14.04% |
| Earnings before Tax (EBT) 1 | 105.5 | 76.32 | 25.23 | 290.6 | 427.6 | 386 |
| Net income 1 | 70.74 | 67.99 | 25.3 | 237.8 | 394.1 | 352.3 |
| Net margin | 6.56% | 5.62% | 2.05% | 12.7% | 18.76% | 16.29% |
| EPS 2 | 0.1250 | 0.1200 | 0.0400 | 0.3800 | 0.6300 | 0.5600 |
| Free Cash Flow 1 | -101.8 | -72.92 | -456.3 | -132.9 | -17.99 | 285.4 |
| FCF margin | -9.44% | -6.03% | -36.97% | -7.1% | -0.86% | 13.19% |
| FCF Conversion (EBITDA) | - | - | - | - | - | 57.17% |
| FCF Conversion (Net income) | - | - | - | - | - | 81.01% |
| Dividend per Share 2 | 0.0375 | - | 0.0200 | 0.0500 | 0.1260 | 0.1680 |
| Announcement Date | 05/03/19 | 22/04/20 | 26/02/21 | 19/04/22 | 24/04/23 | 25/04/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 1,007 | 1,137 | 1,180 | 1,385 | 1,406 | 1,034 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 3.853 x | 4.012 x | 4.754 x | 4.087 x | 3.6 x | 2.071 x |
| Free Cash Flow 1 | -102 | -72.9 | -456 | -133 | -18 | 285 |
| ROE (net income / shareholders' equity) | 6.5% | 5.9% | 1.64% | 13.3% | 18% | 12.9% |
| ROA (Net income/ Total Assets) | 3.24% | 2.66% | 1.67% | 2.83% | 2.86% | 3.74% |
| Assets 1 | 2,183 | 2,560 | 1,517 | 8,403 | 13,788 | 9,419 |
| Book Value Per Share 2 | 2.080 | 2.170 | 2.810 | 3.170 | 3.750 | 4.420 |
| Cash Flow per Share 2 | 0.4500 | 0.5300 | 0.2900 | 0.3600 | 0.3200 | 0.7600 |
| Capex 1 | 356 | 204 | 203 | 272 | 185 | 129 |
| Capex / Sales | 33.03% | 16.84% | 16.46% | 14.54% | 8.82% | 5.98% |
| Announcement Date | 05/03/19 | 22/04/20 | 26/02/21 | 19/04/22 | 24/04/23 | 25/04/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +15.25% | 1.07B | |
| +5.09% | 105B | |
| -3.11% | 64.71B | |
| +74.29% | 49.72B | |
| +15.53% | 38.6B | |
| +5.11% | 32.54B | |
| +10.79% | 19.94B | |
| +13.07% | 16.92B | |
| +18.38% | 15.2B | |
| +4.83% | 14.39B |
- Stock Market
- Equities
- 002125 Stock
- Financials Xiangtan Electrochemical Scientific Co.,Ltd